Biomedical Research Centre news

Orchard Therapeutics logo

NIHR GOSH BRC spinout Orchard Therapeutics signs strategic agreement with GSK

13 Apr 2018, 1:10 p.m.

GSK and Orchard Therapeutics today announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for pat

Read more

GOSH patient James

UK-wide consortium to transform treatment for children and young people with arthritis and uveitis

27 Mar 2018, 5 p.m.

Researchers from the UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) will lead a UK-wide effort to drive the development of new, targeted treatments for children and young people with juvenile idiopathic art

Read more

GOSH researcher Karin Straathof in the lab

Dr Karin Straathof receives Sparks Early Career Investigator Award

27 Mar 2018, 2:28 p.m.

Dr Karin Straathof has been awarded the prestigious Sparks Simon Newell Early Career Investigator award in recognition of her outstanding work focused on understanding and harnessing the power of the immune system in treatment of childhood cancer.

Read more

100,000 Genomes Project hits half way mark

21 Feb 2018, 4:02 p.m.

The pioneering 100,000 Genomes Project has reached the 50,000 genomes landmark. It’s a milestone that has only been made possible through the generous participation of tens of thousands of patients and their families, including 1,492 GOSH families.

Read more

Gut stem cells

Towards stem cell therapies for gut disorders

9 Feb 2018, 5:50 p.m.

Researchers at Great Ormond Street Hospital (GOSH) have taken the first steps towards using stem cells to repair damaged gut tissue in a pioneering new study that could hold promise for children and adults with serious gastrointestinal disorders.

Read more